Kiran Mazumdar-Shaw’s Immuneel Raises Over ₹100 Crore to Bolster Cancer Cell Therapy Innovations.
SKIP_POST
Source: The Economic Times
(Expert Note: This report was prepared by the Wealthova IPO team.)
⚡⚡Latest:
- CRISIL’s Dharmakirti Joshi Rates India’s Growth Durability at 7/10, Citing Abundant Funds But Lacking Will for Private Capex.
- Groundbreaking Innovation: Hong Kong’s First 24-Hour Convenience Store to be Operated Solely by a Humanoid Robot!
- Alfred Winslow Jones Highlights the Psychological Barriers to Short Selling: ‘Not Everyone is Congenitally Equipped to Sell Short.’
- Kiran Mazumdar-Shaw’s Immuneel Raises Over ₹100 Crore to Bolster Cancer Cell Therapy Innovations.
- Elara Securities’ Garima Kapoor: India’s 6.5% Growth Rate Won’t Propel Us to ‘Viksit Bharat’
Tuesday, June 9, 2026
Smart Market Insights